Ubs Group Ag Mimedx Group, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 279,768 shares of MDXG stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

279,768

Previous 120,568 132.04%

Holding current value

$2.65 Million

Previous $835,000 97.96%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.65 - $7.76 $899,480 - $1.24 Million	159,200 Added 132.04%	279,768 $1.65 Million
Q2 2024 Aug 13, 2024	SELL	$6.16 - $8.08 $971,684 - $1.27 Million	-157,741 Reduced 56.68%	120,568 $835,000
Q1 2024 May 13, 2024	BUY	$7.61 - $8.63 $293,251 - $332,557	38,535 Added 16.07%	278,309 $2.14 Million
Q4 2023 Feb 09, 2024	BUY	$5.7 - $9.14 $681,862 - $1.09 Million	119,625 Added 99.56%	239,774 $2.1 Million
Q3 2023 Nov 09, 2023	BUY	$6.35 - $8.16 $37,274 - $47,899	5,870 Added 5.14%	120,149 $875,000
Q2 2023 Aug 11, 2023	BUY	$3.14 - $6.61 $34,772 - $73,199	11,074 Added 10.73%	114,279 $755,000
Q1 2023 May 12, 2023	SELL	$2.97 - $4.81 $124,520 - $201,664	-41,926 Reduced 28.89%	103,205 $351,000
Q4 2022 Feb 08, 2023	BUY	$2.63 - $3.45 $281,912 - $369,808	107,191 Added 282.53%	145,131 $403,000
Q3 2022 Nov 10, 2022	SELL	$2.71 - $4.22 $117,489 - $182,953	-43,354 Reduced 53.33%	37,940 $109,000
Q2 2022 Aug 10, 2022	SELL	$3.17 - $5.0 $487,584 - $769,060	-153,812 Reduced 65.42%	81,294 $282,000
Q1 2022 May 16, 2022	BUY	$4.27 - $6.27 $19,219 - $28,221	4,501 Added 1.95%	235,106 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$5.7 - $8.48 $842,511 - $1.25 Million	147,809 Added 178.52%	230,605 $1.39 Million
Q3 2021 Nov 15, 2021	BUY	$5.52 - $15.83 $339,678 - $974,114	61,536 Added 289.44%	82,796 $502,000
Q2 2021 Aug 13, 2021	SELL	$9.02 - $12.72 $85,554 - $120,649	-9,485 Reduced 30.85%	21,260 $266,000
Q1 2021 May 12, 2021	BUY	$8.48 - $11.28 $89,676 - $119,286	10,575 Added 52.43%	30,745 $316,000
Q4 2020 Feb 11, 2021	BUY	$5.32 - $10.17 $107,304 - $205,128	20,170 New	20,170 $183,000
Q4 2018 Feb 14, 2019	SELL	$1.15 - $6.45 $240,210 - $1.35 Million	-208,879 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.22 - $6.33 $260,452 - $512,008	80,886 Added 63.2%	208,879 $1.29 Million
Q2 2018 Aug 14, 2018	SELL	$5.39 - $8.96 $3.4 Million - $5.65 Million	-630,718 Reduced 83.13%	127,993 $817,000
Q1 2018 May 15, 2018	BUY	$6.69 - $17.96 $4.43 Million - $11.9 Million	661,559 Added 680.95%	758,711 $5.29 Million
Q4 2017 Feb 14, 2018	SELL	$10.87 - $13.9 $407,298 - $520,833	-37,470 Reduced 27.83%	97,152 $1.23 Million
Q3 2017 Nov 14, 2017	BUY	$11.86 - $17.34 $144,110 - $210,698	12,151 Added 9.92%	134,622 $1.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,266 Added 6.31%	122,471 $1.83 Million
Q1 2017 Nov 14, 2017	BUY	N/A	115,205	115,205 $1.1 Million

Others Institutions Holding MDXG

# of Institutions

208

Shares Held

98.1M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.08B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account